Government Affairs
Refine Search
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Pharmaceutical
Several foreign companies are willing to tie-up with Indian pharmaceutical companies. As Ambassadors of 100 countries arrived in Pune near Mumbai over the weekend to visit the Serum Institute of India and Gennova Biopharma facility, many have expressed keen interest. 7 December 2020
Pharmaceutical
President-elect Joe Biden has nominated former Congressman and California Attorney General Xavier Becerra for the position of HHS Secretary. 7 December 2020
Generics
India's Health Ministry is to revoke an earlier notification and allow export of oseltamivir phosphate and zanamivir, based on the recommendations of the Drugs Technical Advisory Board and Drugs Consultative Committee. 3 December 2020
Pharmaceutical
The European pharmaceutical industry has thrown its weight behind the use of artificial intelligence (AI) in drug development, with the publication of a new paper advocating its use. 3 December 2020
Pharmaceutical
The Association of Foreign Pharmaceutical Manufacturers (AIPM), a trade association which unites more than 60 global drugmakers operating in the Russian market, has appealed to the country’s Federal Antimonopoly Service (FAS) to limit participation of a drug with the international non-proprietary name (INN) insulin glargine in tenders for public procurements in the Russian pharmaceutical market, according to recent statements by an official spokesman of the Association and some local media reports. 1 December 2020
Pharmaceutical
An intense debate is going on in India on whether patented drugs should be selected and identified for inclusion in the National List of Essential Medicines (NLEM) 2020, which is being finalized by the Expert Committee constituted by the Ministry of Health. 27 November 2020
Pharmaceutical
UK Chancellor of the Exchequer Rishi Sunak has unveiled the government's spending plans for the coming year, including for National Health Service (NHS) funding, clinical research, and R&D. 26 November 2020
Pharmaceutical
The Russian government has ordered preparations for changes to the rules for registration of drugs in the Russian pharmaceutical market – in a move aimed to speed the launch of the drugs by three to five years, according to recent statements by an official spokesman of the government and some local media reports. 23 November 2020
Pharmaceutical
Two weeks after Americans voted in the presidential election, the losing candidate, Donald Trump, remains in denial over the outcome of the poll. 18 November 2020
Pharmaceutical
The Russian government may consider increasing state funding for public procurements of drugs in the next several years, according to recent statements, made by an official spokesman of the federal government and some local media reports. 17 November 2020
Pharmaceutical
The high and rising cost of prescription drugs in the United States remains a concern for patients, physicians, payers, and policy makers. It is also a key priority for the US Food and Drug Administration, the Trump administration, and the Department of Health and Human Services (HHS). 16 November 2020
Pharmaceutical
Brazil’s pharmaceutical industry is the largest in Latin America and currently the seventh biggest in the world though, according to projections from IQVIA, it could be in fifth position in 2023. 16 November 2020
Generics
Private equity (PE) investors are betting big on Indian drug makers, especially those that manufacture active pharmaceutical ingredients (APIs), with investments jumping more than fourfold so far this year. 11 November 2020
Biotechnology
In timely fashion, a deal has been announced for the European Commission (EC) to be supplied with 200 million doses of the Pfizer and BioNTech mRNA-based vaccine candidate against COVID-19. 11 November 2020
Biotechnology
The US Department of Health and Human Services on Tuesday announced plans to allocate initial doses of Eli Lilly's investigational monoclonal antibody therapeutic, bamlanivimab, which received emergency use authorization from the US Food and Drug Administration November 9 for the treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19. 11 November 2020
Generics
Pharmasynthez, one of Russia’s leading drugmakers, has asked for permission to begin production of a generic of remdesivir, an original drug from US antivirals giant Gilead Sciences, reports The Pharma Letter’s local correspondent. 10 November 2020
Pharmaceutical
Russian patients have called on the national government to take measures to prevent the ever-growing shortage of drugs in the domestic market, particular those that could be recommended for the treatment of COVID-19. 10 November 2020
Pharmaceutical
No fewer than six bodies representing the pharmaceutical industry in the UK and Europe have expressed relief at the agreement for a phased process for implementing medicines regulation in Northern Ireland up to December 31, 2021. 9 November 2020
Pharmaceutical
In response to the Request for Input on Modernizing the 340B Drug Pricing Program issued by Representative Greg Walden and Senator Lamar Alexander, trade body Pharmaceutical Research and Manufacturers of America (PhRMA) has outlined a number of commonsense ways policymakers can get the 340B program back on track and refocused on patients. 3 November 2020
Pharmaceutical
The UK would gain from more fully recognizing the long-term value of better therapies for cancers and other severe illnesses. 2 November 2020
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze